Selected research
Industry Research
Pediatric Oncology Treatment Industry Research Report 2026
Market perspective
The global Pediatric Oncology Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Pediatric Oncology Treatment market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Pediatric Oncology Treatment market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Pediatric Oncology Treatment market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Pediatric Oncology Treatment include United Therapeutics Corporation, Apeiron Biologics, Baxter, Cellectar Biosciences, Pfizer, Bayer, Macrogenics, Sartorius and Merck, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Pediatric Oncology Treatment market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Pediatric Oncology Treatment.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pediatric Oncology Treatment Market by Company
United Therapeutics Corporation
Apeiron Biologics
Baxter
Cellectar Biosciences
Pfizer
Bayer
Macrogenics
Sartorius
Merck
BioNTech
Dr.Reddy's Laboratories
Pediatric Oncology Treatment Segment by Type
Radiotherapy
Chemotherapy
Pediatric Oncology Treatment Segment by Application
Leukemia
Neuroblastoma
Brain Cancer
Retinoblastoma
Lymphoma
Others
Pediatric Oncology Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pediatric Oncology Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pediatric Oncology Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pediatric Oncology Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Pediatric Oncology Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Radiotherapy
- Chemotherapy
Applications
- Leukemia
- Neuroblastoma
- Brain Cancer
- Retinoblastoma
- Lymphoma
- Others
Companies covered
- United Therapeutics Corporation
- Apeiron Biologics
- Baxter
- Cellectar Biosciences
- Pfizer
- Bayer
- Macrogenics
- Sartorius
- Merck
- BioNTech
- Dr.Reddy's Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pediatric Oncology Treatment by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Radiotherapy
- 2.2.3 Chemotherapy
- 2.3 Pediatric Oncology Treatment by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Leukemia
- 2.3.3 Neuroblastoma
- 2.3.4 Brain Cancer
- 2.3.5 Retinoblastoma
- 2.3.6 Lymphoma
- 2.3.7 Others
- 2.4 Assumptions and Limitations
3 Pediatric Oncology Treatment Breakdown Data by Type
- 3.1 Global Pediatric Oncology Treatment Historic Market Size by Type (2021-2026)
- 3.2 Global Pediatric Oncology Treatment Forecasted Market Size by Type (2027-2032)
4 Pediatric Oncology Treatment Breakdown Data by Application
- 4.1 Global Pediatric Oncology Treatment Historic Market Size by Application (2021-2026)
- 4.2 Global Pediatric Oncology Treatment Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Pediatric Oncology Treatment Market Perspective (2021-2032)
- 5.2 Global Pediatric Oncology Treatment Growth Trends by Region
- 5.2.1 Global Pediatric Oncology Treatment Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Pediatric Oncology Treatment Historic Market Size by Region (2021-2026)
- 5.2.3 Pediatric Oncology Treatment Forecasted Market Size by Region (2027-2032)
- 5.3 Pediatric Oncology Treatment Market Dynamics
- 5.3.1 Pediatric Oncology Treatment Industry Trends
- 5.3.2 Pediatric Oncology Treatment Market Drivers
- 5.3.3 Pediatric Oncology Treatment Market Challenges
- 5.3.4 Pediatric Oncology Treatment Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Pediatric Oncology Treatment Players by Revenue
- 6.1.1 Global Top Pediatric Oncology Treatment Players by Revenue (2021-2026)
- 6.1.2 Global Pediatric Oncology Treatment Revenue Market Share by Players (2021-2026)
- 6.2 Global Pediatric Oncology Treatment Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Pediatric Oncology Treatment Head Office and Area Served
- 6.4 Global Pediatric Oncology Treatment Players, Product Type & Application
- 6.5 Global Pediatric Oncology Treatment Manufacturers Established Date
- 6.6 Global Pediatric Oncology Treatment Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Pediatric Oncology Treatment Market Size (2021-2032)
- 7.2 North America Pediatric Oncology Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Pediatric Oncology Treatment Market Size by Country (2021-2026)
- 7.4 North America Pediatric Oncology Treatment Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Pediatric Oncology Treatment Market Size (2021-2032)
- 8.2 Europe Pediatric Oncology Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Pediatric Oncology Treatment Market Size by Country (2021-2026)
- 8.4 Europe Pediatric Oncology Treatment Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Pediatric Oncology Treatment Market Size (2021-2032)
- 9.2 Asia-Pacific Pediatric Oncology Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Pediatric Oncology Treatment Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Pediatric Oncology Treatment Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Pediatric Oncology Treatment Market Size (2021-2032)
- 10.2 South America Pediatric Oncology Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Pediatric Oncology Treatment Market Size by Country (2021-2026)
- 10.4 South America Pediatric Oncology Treatment Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Pediatric Oncology Treatment Market Size (2021-2032)
- 11.2 Middle East & Africa Pediatric Oncology Treatment Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Pediatric Oncology Treatment Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Pediatric Oncology Treatment Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 United Therapeutics Corporation
- 12.1.1 United Therapeutics Corporation Company Information
- 12.1.2 United Therapeutics Corporation Business Overview
- 12.1.3 United Therapeutics Corporation Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.1.4 United Therapeutics Corporation Pediatric Oncology Treatment Product Portfolio
- 12.1.5 United Therapeutics Corporation Recent Developments
- 12.2 Apeiron Biologics
- 12.2.1 Apeiron Biologics Company Information
- 12.2.2 Apeiron Biologics Business Overview
- 12.2.3 Apeiron Biologics Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.2.4 Apeiron Biologics Pediatric Oncology Treatment Product Portfolio
- 12.2.5 Apeiron Biologics Recent Developments
- 12.3 Baxter
- 12.3.1 Baxter Company Information
- 12.3.2 Baxter Business Overview
- 12.3.3 Baxter Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.3.4 Baxter Pediatric Oncology Treatment Product Portfolio
- 12.3.5 Baxter Recent Developments
- 12.4 Cellectar Biosciences
- 12.4.1 Cellectar Biosciences Company Information
- 12.4.2 Cellectar Biosciences Business Overview
- 12.4.3 Cellectar Biosciences Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.4.4 Cellectar Biosciences Pediatric Oncology Treatment Product Portfolio
- 12.4.5 Cellectar Biosciences Recent Developments
- 12.5 Pfizer
- 12.5.1 Pfizer Company Information
- 12.5.2 Pfizer Business Overview
- 12.5.3 Pfizer Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.5.4 Pfizer Pediatric Oncology Treatment Product Portfolio
- 12.5.5 Pfizer Recent Developments
- 12.6 Bayer
- 12.6.1 Bayer Company Information
- 12.6.2 Bayer Business Overview
- 12.6.3 Bayer Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.6.4 Bayer Pediatric Oncology Treatment Product Portfolio
- 12.6.5 Bayer Recent Developments
- 12.7 Macrogenics
- 12.7.1 Macrogenics Company Information
- 12.7.2 Macrogenics Business Overview
- 12.7.3 Macrogenics Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.7.4 Macrogenics Pediatric Oncology Treatment Product Portfolio
- 12.7.5 Macrogenics Recent Developments
- 12.8 Sartorius
- 12.8.1 Sartorius Company Information
- 12.8.2 Sartorius Business Overview
- 12.8.3 Sartorius Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.8.4 Sartorius Pediatric Oncology Treatment Product Portfolio
- 12.8.5 Sartorius Recent Developments
- 12.9 Merck
- 12.9.1 Merck Company Information
- 12.9.2 Merck Business Overview
- 12.9.3 Merck Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.9.4 Merck Pediatric Oncology Treatment Product Portfolio
- 12.9.5 Merck Recent Developments
- 12.10 BioNTech
- 12.10.1 BioNTech Company Information
- 12.10.2 BioNTech Business Overview
- 12.10.3 BioNTech Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.10.4 BioNTech Pediatric Oncology Treatment Product Portfolio
- 12.10.5 BioNTech Recent Developments
- 12.11 Dr.Reddy's Laboratories
- 12.11.1 Dr.Reddy's Laboratories Company Information
- 12.11.2 Dr.Reddy's Laboratories Business Overview
- 12.11.3 Dr.Reddy's Laboratories Revenue in Pediatric Oncology Treatment Business (2021-2026)
- 12.11.4 Dr.Reddy's Laboratories Pediatric Oncology Treatment Product Portfolio
- 12.11.5 Dr.Reddy's Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst